Search Results
Targeting public neoantigens in cancer immunotherapies
Optimizing public neoantigen-targeting immunotherapies
Neoantigens: promising targets for cancer therapy
Immunogenicity and Therapeutic Targeting of Recurrently Mutated "Public" Neoantigens
Harnessing Neoantigens for Individualized Cancer Immunotherapy
Targeting Tumor Mutations for Personalized Cancer Immunotherapy
Therapeutic targeting of recurrently mutated ‘public’ neoantigens using TCR gene therapy
Evaluating the therapeutic potential of PIK3CA-derived public neoantigens
AACR 2023 Recap with Dr. Christopher Klebanoff
Cancer Neoantigens as Targets for Natural and Therapeutic Anti-Tumor Responses
Harnessing neoantigens for individualized cancer immunotherapy
"Revisiting the Neoantigen Approach for Cancer Immunotherapy" by Dr. Yardena Samuels
